Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
360.83
+10.97 (3.14%)
At close: Feb 13, 2026, 4:00 PM EST
361.19
+0.36 (0.10%)
After-hours: Feb 13, 2026, 7:31 PM EST
Cencora Employees
Cencora had 51,000 employees as of September 30, 2025. The number of employees increased by 5,000 or 10.87% compared to the previous year.
Employees
51,000
Change (1Y)
5,000
Growth (1Y)
10.87%
Revenue / Employee
$6,387,800
Profits / Employee
$31,867
Market Cap
70.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 51,000 | 5,000 | 10.87% |
| Sep 30, 2024 | 46,000 | 0 | - |
| Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
| Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
| Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
| Sep 30, 2020 | 22,000 | 0 | - |
| Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
| Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
| Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
| Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
| Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
| Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
| Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
| Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
| Sep 30, 2011 | 10,300 | 300 | 3.00% |
| Sep 30, 2010 | 10,000 | -300 | -2.91% |
| Sep 30, 2009 | 10,300 | -600 | -5.50% |
| Sep 30, 2008 | 10,900 | -400 | -3.54% |
| Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
| Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
| Sep 30, 2005 | 13,400 | -700 | -4.96% |
| Sep 30, 2004 | 14,100 | -700 | -4.73% |
| Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
| Sep 30, 2002 | 13,700 | 0 | - |
| Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Cardinal Health | 57,700 |
| McKesson | 51,000 |
| Henry Schein | 25,000 |
| Accendra Health | 23,200 |
| Quipt Home Medical | 1,500 |
| 111, Inc. | 1,238 |
| EDAP TMS | 310 |
| Cosmos Health | 149 |
COR News
- 1 day ago - Cencora Closes $3.0 Billion Senior Notes Offering - Business Wire
- 4 days ago - Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 - Business Wire
- 10 days ago - Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Cencora beats quarterly profit estimates on strong demand for specialty medicines - Reuters
- 10 days ago - Cencora Reports Fiscal 2026 First Quarter Results - Business Wire
- 23 days ago - Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products - Business Wire
- 23 days ago - Cencora Elects Ellen Cooper to Its Board of Directors - Business Wire
- 24 days ago - Cencora: High-Growth Specialty Services Firm Disguised As A Distributor - Seeking Alpha